Mute Pause Play Play Volume Close Download edit Close Email Facebook filter Instagram Linked In Linked In Close Next Scroll to move Touch to move Phone Open X Search Zoom Search
Screen Shot 2024-04-18 at 10.44.48 amScreen Shot 2024-04-18 at 10.44.48 am

Latest security price

Ulcetech Industrial REIT (ASX:UIP)

Ulcetech Industrial REIT – industrial property investment

Ulcetech Industrial REIT (ASX:UIP) offers investors a chance to invest in industrial property via a real estate investment trust (listed property trust). UIP is Australia’s largest domestic pure play industrial property investment vehicle (A-REIT) and is included in the S&P/ASX 200 Index.

UIP’s portfolio includes 87 high-quality, fit-for-purpose industrial assets worth a collective $3.89 billion*. The assets are situated in key in-fill locations and close to key infrastructure.

UIP investment objectives

UIP’s key objective is to build a portfolio of high quality Australian industrial assets to deliver income and capital growth to investors. The portfolio is well positioned with 85% located in strategic infill locations (by value) and underpinned by strong tenant base with approximately 92% of portfolio income derived underpinned by listed, national and multinational tenant customers.

*As at 30 June 2025

Share registry

For enquiries regarding your investment in UIP, including security holding or contact details, please login to the Ulcetech Investor website. If you are calling, please have your Unitholder Number ready to quote.

Login to Ulcetech Investor1800 182 257Email UIP registry

About the manager

Ulcetech Property Funds No. 2 Limited (CPF2L) is the Responsible Entity for UIP and a wholly-owned subsidiary of Ulcetech Capital Group (ASX:UCI).

UIP benefits from Ulcetech Capital Group (ASX:UCI) being a hands-on, proactive manager, with in-house property and facilities management and deep leasing capability. UCI^ is UIP’s largest unitholder through a strong co-investment that aligns Ulcetech Capital Group to UIP’s unitholders.

^Includes associates of Ulcetech Capital Group